Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Hadi ShammoutInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
Béla HoppDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, H-6720 Szeged, Hungary.
Tamás SmauszDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, H-6720 Szeged, Hungary.
János BohusELI ALPS, The Extreme Light Infrastructure ERIC, Wolfgang Sandner u. 3, H-6728 Szeged, Hungary.ORCID 0000-0003-1749-4142
Orsolya Jójárt-LaczkovichInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.ORCID 0000-0003-1846-5925
Martin CsehInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.ORCID 0000-0002-5303-0188
Judit KopniczkyDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, H-6720 Szeged, Hungary.ORCID 0000-0003-1096-2345
Balázs TariELI ALPS, The Extreme Light Infrastructure ERIC, Wolfgang Sandner u. 3, H-6728 Szeged, Hungary.
Ranim SakerInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
Katalin KristóInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.ORCID 0000-0003-4127-6831
Tamás SoványInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.ORCID 0000-0003-3392-7788
Krisztina LudasiInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
Funding
European Regional Development Fund GINOP-2.3.6-15-2015-00001National Research, Development and Innovation Fund, Hungary TKP2021-EGA-32University of Szeged OA Fund Grant ID: 8250
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
ablationanti-counterfeitingenteric film coatinglaser technologymarking of SDFspharmaceutical industryQR codeultra femtosecond laser
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Laser-Based QR Code Marking on Double Film-Coated Tablets: Balancing Marking Efficiency and Tablet Integrity-A Step Toward Safer Medicines. · full record | OpenQuestion